Data / Form D filings / CytoBioscience, Inc.
CytoBioscience, Inc.: Form D filings
CytoBioscience, Inc., a biotechnology company in San Antonio, TX, filed 7 Form D notices with the SEC between 2015 and 2018. The latest, on March 16, 2018, reports $1.5 million sold of a $1.5 million offering to 3 investors.
Find out what CytoBioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3463 MAGIC DRIVE, SUITE 120, San Antonio, TX, 78229
- Phone
- (210) 767-2727
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1637514
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 16, 2018 | Amendment | $1,530,000 | $1,530,000 | $0 | 3 | Mar 1, 2018 | sec.gov |
| Mar 15, 2018 | New notice | $1,530,000 | $1,530,000 | $0 | 3 | Mar 14, 2018 | sec.gov |
| Jan 23, 2018 | Amendment | $21,821,845 | $15,821,845 | $6,000,000 | 11 | Mar 11, 2015 | sec.gov |
| Jan 22, 2018 | Amendment | $21,821,845 | $15,821,845 | $6,000,000 | 11 | Mar 11, 2015 | sec.gov |
| Aug 10, 2016 | Amendment | $21,821,845 | $15,821,845 | $6,000,000 | 11 | Mar 11, 2015 | sec.gov |
| Mar 26, 2015 | New notice | $18,000,000 | $6,637,345 | $11,362,655 | 3 | Mar 11, 2015 | sec.gov |
| Mar 26, 2015 | New notice | Indefinite | $0 | Indefinite | 2 | Mar 6, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Alan R. Dean | Director | |
| Paul R. Castella | Director | |
| James R. Garvin | Executive Officer, Director | |
| Ian R. Clements | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Mar 12, 2018 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CytoBioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.